icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
W1ssetJ48J9D1dGr
Listen
